ESMO Targeted Anticancer Therapies (TAT) Congress 2024

The ESMO Targeted Anticancer Therapies (TAT) Congress 2024 is dedicated to targeted agents for the treatment of cancer and includes topics such as:

• Clinical studies
• Biomarkers
• Drug development methodology
• Drug design
• Immuno-oncology clinical studies
• Genomics and proteomics
• New immunological targets
• Molecular profiling and diagnosis
• Phase 1 studies
• Preclinical drug profiling
• Targeted drug delivery
• Preclinical test models
• Vaccines
• Translational studies
• New molecular targets

The ESMO Targeted Anticancer Therapies (TAT) Congress 2024 brings together delegates from industry, academia and governmental agencies with an interest in the development of innovative cancer therapies.

The ESMO Targeted Anticancer Therapies (TAT) Congress 2024 will be held in Paris, France on 26-28 Feb 2024.